Edition:
United Kingdom

Avadel Pharmaceuticals PLC (AVDL.OQ)

AVDL.OQ on NASDAQ Stock Exchange Global Market

8.40USD
8:59pm GMT
Change (% chg)

$-0.34 (-3.89%)
Prev Close
$8.74
Open
$8.79
Day's High
$8.80
Day's Low
$8.34
Volume
41,926
Avg. Vol
50,220
52-wk High
$12.30
52-wk Low
$7.53

Get access to over 18 million research reports from over 1,700 sources.

For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.

Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.

Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:

  • ownership
  • filings
  • deals
  • private equity
  • third-party document and information retrieval
  • estimates
  • fundamentals
  • economics
  • events
  • news
  • and much, much more…

Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.

Name Age Since Current Position

Craig Stapleton

71 2014 Non-Executive Independent Chairman of the Board

Michael Anderson

68 2012 Chief Executive Officer, Director

Michael Kanan

53 2015 Senior Vice President, Chief Financial Officer

Gregory Divis

50 2017 Executive Vice President, Chief Commercial Officer

Phillandas Thompson

42 2013 Senior Vice President, General Counsel, Corporate Secretary